SEC 13F Intelligence

Rench Wealth Management, Inc. / ABT

Rench Wealth Management, Inc.’s Abbott Laboratories Position

Does Rench Wealth Management, Inc. own Abbott Laboratories (ABT)? Yes — 67.0K shares worth $7M (+2.07% of its 13F portfolio) as of Q1 2026, down from 67.2K shares the prior filed quarter.

Position Value
$7M
Q1 2026
Shares
67.0K
% of Portfolio
+2.07%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $3MQ4 ’18Q1 ’19: $4MQ2 ’19: $4MQ3 ’19: $4MQ4 ’19: $4MQ4 ’19Q1 ’20: $5MQ2 ’20: $6MQ3 ’20: $7MQ4 ’20: $7MQ4 ’20Q1 ’21: $8MQ2 ’21: $8MQ3 ’21: $8MQ4 ’21: $10MQ4 ’21Q1 ’22: $8MQ2 ’22: $7MQ3 ’22: $6MQ4 ’22: $7MQ4 ’22Q1 ’23: $7MQ2 ’23: $7MQ3 ’23: $7MQ4 ’23: $8MQ4 ’23Q1 ’24: $8MQ2 ’24: $7MQ3 ’24: $8MQ4 ’24: $8MQ4 ’24Q1 ’25: $9MQ2 ’25: $9MQ3 ’25: $9MQ4 ’25: $8MQ4 ’25Q1 ’26: $7Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202667.0K$7M+2.07%
Q4 202567.2K$8M+2.41%
Q3 202567.9K$9M+2.67%
Q2 202567.5K$9M+2.90%
Q1 202568.4K$9M+3.13%
Q4 202468.6K$8M+2.65%
Q3 202469.4K$8M+2.72%
Q2 202469.1K$7M+2.58%
Q1 202469.2K$8M+3.01%
Q4 202369.0K$8M+3.20%
Q3 202368.5K$7M+3.05%
Q2 202367.9K$7M+3.24%
Q1 202366.3K$7M+3.21%
Q4 202265.6K$7M+3.66%
Q3 202264.8K$6M+3.52%
Q2 202264.6K$7M+3.59%
Q1 202264.5K$8M+3.47%
Q4 202167.6K$10M+4.29%
Q3 202169.0K$8M+4.05%
Q2 202169.0K$8M+3.99%
Q1 202168.7K$8M+4.28%
Q4 202068.3K$7M+4.21%
Q3 202066.8K$7M+4.63%
Q2 202067.1K$6M+4.13%
Q1 202067.5K$5M+4.14%
Q4 201948.8K$4M+2.44%
Q3 201945.4K$4M+2.45%
Q2 201944.4K$4M+2.39%
Q1 201945.5K$4M+2.38%
Q4 201846.6K$3M+2.47%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rench Wealth Management, Inc.’s full portfolio or all institutional holders of ABT.